|
|
||||||||
Ann Thorac Surg 2001;71:2085
© 2001 The Society of Thoracic Surgeons
a The University College London Hospitals, Holmes Sellors Cardiothoracic Unit, The Middlesex Hospital, London, England, United Kingdom
e-mail: rmhkdcw@ucl.ac.uk
To the Editor
The recent suggestion by Wandschneider and colleagues [1] that avoiding cardiopulmonary bypass reduces perioperative cerebral injury remains an interesting hypothesis that has yet to be adequately tested. The hypothesis does not, however, seem to be supported by data from their study. For several reasons, serum S100ß is a controversial marker of cerebral injury during cardiac operation. These are not addressed in the article. First, although widely used, the Sangtec assay remains unvalidated by published data [2]. There are
Related Article
Ann. Thorac. Surg. 2001 71: 2085-2086.
This article has been cited by other articles:
![]() |
K. G. Shann, D. S. Likosky, J. M. Murkin, R. A. Baker, Y. R. Baribeau, G. R. DeFoe, T. A. Dickinson, T. J. Gardner, H. P. Grocott, G. T. O'Connor, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 283 - 290.e3. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |